Canada Life
OGN icon

Canada Life’s Organon & Co OGN Stock Holding History

Canada Life’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-79,684
Closed -$1.38M – 2205
2023
Q3 		$1.38M Buy
79,684
+10,940
+16% +$228K ﹤0.01% 1373
2023
Q2 		$1.44M Sell
68,744
-3,387
-5% -$73.6K ﹤0.01% 1358
2023
Q1 		$1.7M Buy
72,131
+671
+0.9% +$18K ﹤0.01% 1299
2022
Q4 		$2M Sell
71,460
-38,546
-35% -$986K 0.01% 1236
2022
Q3 		$2.57M Buy
110,006
+10,214
+10% +$308K 0.01% 1040
2022
Q2 		$3.37M Buy
99,792
+2,097
+2% +$73.4K 0.01% 865
2022
Q1 		$3.58M Buy
+97,695
New +$3.34M 0.01% 892
2021
Q4 		– Sell
-171,264
Closed -$5.65M – 2537
2021
Q3 		$5.65M Buy
+171,264
New +$5.48M 0.01% 694

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Canada Life's OGN Position: Q4 2023 in Review

Canada Life sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 79,684 shares — an estimated $1.38M sold.

Canada Life first reported a position in OGN in Q3 2021 and held it in 8 quarters. The position peaked at $5.65M in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Canada Life reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Canada Life sold 79,684 Organon & Co shares in Q4 2023, an estimated $1.38M.
  • Canada Life first reported a position in Organon & Co in Q3 2021 and held it in 8 quarters.
  • Canada Life's Organon & Co position peaked at $5.65M in Q3 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.